Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil vs IUI with Clomiphene for Unexplained Infertility
NCT06178523Phase 4
Key facts
- Status
- Completed
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Countries
- 1
- Sponsor
- Batterjee Medical College
- Modality
- Small Molecules
- Drugs
- ASP-001
- Conditions
- Unexplained infertility
01
Overview
Phase 4, randomised, double-blind trial of ASP-001 in Unexplained infertility (3 arms), sponsored by Batterjee Medical College. Primary endpoint: Pregnancy outcome. Started Jan 2024; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
Sildenafil & Clomiphene
Clomiphene + Vaginal Sildenafil
IUI & Clomiphene
Clomiphene + IUI
Clomiphene only
Clomiphene alone
03
Who it enrols
Saudi married women aged 18-35 with primary unexplained infertility (failed to conceive >2 years) and BMI < 30.
04
Endpoints
Primary
Pregnancy outcome
Beyond the preview
Go deeper on NCT06178523.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06178523.